Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML)

Abhishek Mangaonkar, Jenna Fernandez, Ashya Burgess, Kristen McCullough, Christy Finke, Terra Lasho, Michelle Amundson, Antoine Saliba, Aasiya Matin, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Betsy Knopf, Thomas Witzig, Mrinal Patnaik

Blood (2025) 146 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2025-2079

Published: 2025

Journal Articles

MC210807: Phase 1 clinical trial assessing the safety and efficacy of onvansertib, a novel, oral, PLK1 inhibitor in Relapsed/Refractory myeloproliferative chronic myelomonocytic leukemia (CMML).

Abhishek Mangaonkar, Kristen McCullough, Susan Geyer, Ashya Burgess, Kimberly Rice, Eric Asmus, Patricia Koenig, Terra Lasho, Christy Finke, Rachel Reither, Ryan Carr, Jenna Fernandez, Antoine Saliba, Aref Al-Kali, Martin Fernandez-Zapico, Mrinal Patnaik

Blood (2025) 146 (Supplement 1): 5634.

https://doi.org/10.1182/blood-2025-5634

Published: 2025